Navigation Links
Brooke Shields and the Makers of COPPERTONE(R) Join Together to Launch COPPERTONE(R) NutraShield(TM) - New Sunscreen Contains Antioxidants That Promote Natural Skin Repair
Date:1/27/2009

Dual Defense(TM) Technology Latest Innovation from COPPERTONE(R) Solar Research Center

KENILWORTH, N.J., Jan. 27 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP), the makers of COPPERTONE(R), announced today that actress and model Brooke Shields will become the spokesperson for the brand's new beauty line, COPPERTONE(R) NutraShield(TM) with Dual Defense(TM) - a broad spectrum sunscreen lotion enriched with antioxidants that promote natural skin repair and combat premature skin aging from the sun.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090127/NY62932)

An international beauty icon, Ms. Shields stays current on the latest trends in maintaining optimal skin health and understands how year-round sun exposure can slowly deplete unprotected skin of its radiance over time. "I am excited to work with the COPPERTONE brand to help raise awareness on the need for year-round sun protection and the benefits of antioxidants in promoting natural skin repair," Shields said.

COPPERTONE(R) Adds Antioxidants to Help Replenish Skin

The COPPERTONE NutraShield product line - the latest innovation from the COPPERTONE Solar Research Center - evolves the brand beyond its suncare roots to a new level of antioxidant-enhanced suncare. The power of NutraShield lies in its Dual Defense technology, combining a broad spectrum sunscreen, to protect against UVA and UVB rays, and antioxidants to replenish skin, supporting its natural repair process.

"The changing environment is altering the way people think about the sun's effects on skin. Our research indicates that consumers want not only broad spectrum sunscreens with higher sun protection factors (SPFs) to help prevent sun damage, but also formulas with antioxidants that can help promote natural skin repair," said Patricia Agin, Ph.D., fellow in skincare research and development at the COPPERTONE Solar Research Center. "Our legacy of continuous innovation led to the development of COPPERTONE NutraShield and its Dual Defense technology, providing women an affordable skin-care option that delivers a high level of sun protection as well as antioxidants to help nourish skin."

The COPPERTONE NutraShield line includes a SPF 70+ Faces lotion as well as SPF 70+ and SPF 30 lotions for the body. The product line is available online and at mass retailers across the country.

About COPPERTONE

COPPERTONE, Water BABIES, COPPERTONE SPORT, ultraGUARD and COPPERTONE KIDS are registered trademarks and NutraShield and Dual Defense are trademarks of Schering-Plough HealthCare Products, Inc.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE:

The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for COPPERTONE(R) NUTRASHIELD(TM). Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A. "Risk Factors" in the third quarter 2008 10-Q, filed October 29, 2008.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose
3. Col. Robert E. Shields Joins Palmetto GBAs Board of Directors
4. Football helmet shields can protect against a kick in the face
5. Drug Shields Mice From Emphysema
6. Study Shows Exercise Shields Against Osteoporosis
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Equipping your Sales Force to Influence Hospital Formulary Decision-Makers
9. Hospitals and the Coalition to Protect Floridas Drivers Applaud Lawmakers for Reviving No-Fault Insurance
10. Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines
11. Drug Makers Withdraw Cough, Cold Meds for Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... Advice Media, the industry leader in digital ... companies in North America and has been included in the Inc. 5000 for the second ... honored to be included in the Inc. 5000 rankings for the second year in a ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... ... August 16, 2017 , ... The next Patient Care ... accepted. , Students who successfully complete the seven-week long Patient Care Academy are ... (CNA). The average starting salary for a CNA in Kalamazoo is $24,428.* , As ...
(Date:8/16/2017)... ... August 16, 2017 , ... Greenfield Advisors is honored to be named to ... second year in a row. The Inc. 5000 list honors private businesses across the ... on the list once is a great accomplishment, but for us to be included ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Any Lab ... 5000. The company ranked #4429 on the newly released, 36th annual Inc. 5000 ... a unique look at the most successful companies within the American economy’s most dynamic ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO ... as president, effective Aug. 7, 2017. ... pursue other interests and will serve as president emeritus during ... served us in multiple leadership roles since he joined Diplomat ... and has provided decisive, strategic leadership which continues to benefit ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
Breaking Medicine Technology: